Company intelligence / Profile preview

reThink64 Bionetworks

Fremont, California, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Preclinical

Overview

reThink64 Bionetworks develops advanced technologies for the delivery and distribution of drugs and genetic therapeutics. Their innovations are positioned to significantly improve how medicines—especially complex biologics or gene therapies—are delivered within the body. No specific clinical results have been published yet.

Modalities: Genetic therapeuticsDrug delivery platforms (specific modalities not detailed, but focus is on delivery and distribution technology for drugs and genetic medicines)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on reThink64 Bionetworks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on reThink64 Bionetworks.

Explore the full profile